Literature DB >> 32106791

Prospects for Redifferentiating Agents in the Use of Radioactive Iodine Therapy for Thyroid Cancer.

Sissy M Jhiang1,2, Bhavana Konda3, Jennifer A Sipos2, Fadi A Nabhan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32106791      PMCID： PMC7187962          DOI： 10.1089/thy.2020.0143

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  10 in total

1.  A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.

Authors:  Ji Min Oh; Se Hwan Baek; Prakash Gangadaran; Chae Moon Hong; Ramya Lakshmi Rajendran; Ho Won Lee; Liya Zhu; Arunnehru Gopal; Senthilkumar Kalimuthu; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Thyroid       Date:  2020-02-14       Impact factor: 6.568

2.  Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol.

Authors:  Amir Iravani; Benjamin Solomon; David A Pattison; Price Jackson; Aravind Ravi Kumar; Grace Kong; Michael S Hofman; Tim Akhurst; Rodney J Hicks
Journal:  Thyroid       Date:  2019-11       Impact factor: 6.568

3.  124I Positron Emission Tomography/Computed Tomography Versus Conventional Radioiodine Imaging in Differentiated Thyroid Cancer: A Review.

Authors:  Di Wu; Dorina Ylli; S Layla Heimlich; Kenneth D Burman; Leonard Wartofsky; Douglas Van Nostrand
Journal:  Thyroid       Date:  2019-09-27       Impact factor: 6.568

4.  Molecular therapeutics for anaplastic thyroid cancer.

Authors:  Nikita Pozdeyev; Madison M Rose; Daniel W Bowles; Rebecca E Schweppe
Journal:  Semin Cancer Biol       Date:  2020-01-25       Impact factor: 15.707

5.  Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair.

Authors:  Ryan Robb; Linlin Yang; Changxian Shen; Adam R Wolfe; Amy Webb; Xiaoli Zhang; Marall Vedaie; Motoyasu Saji; Sissy Jhiang; Matthew D Ringel; Terence M Williams
Journal:  Clin Cancer Res       Date:  2019-05-16       Impact factor: 12.531

6.  Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib.

Authors:  S Michael Rothenberg; David G McFadden; Edwin L Palmer; Gilbert H Daniels; Lori J Wirth
Journal:  Clin Cancer Res       Date:  2014-12-30       Impact factor: 12.531

7.  Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.

Authors:  Alan L Ho; Ravinder K Grewal; Rebecca Leboeuf; Eric J Sherman; David G Pfister; Desiree Deandreis; Keith S Pentlow; Pat B Zanzonico; Sofia Haque; Somali Gavane; Ronald A Ghossein; Julio C Ricarte-Filho; José M Domínguez; Ronglai Shen; R Michael Tuttle; Steve M Larson; James A Fagin
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

8.  Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin.

Authors:  Aparna Lakshmanan; Daniel Scarberry; Jill A Green; Xiaoli Zhang; Samia Selmi-Ruby; Sissy M Jhiang
Journal:  Oncotarget       Date:  2015-10-13

9.  Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.

Authors:  Oussama ElMokh; Dorothée Ruffieux-Daidié; Matthias A Roelli; Amandine Stooss; Wayne A Phillips; Jürg Gertsch; Matthias S Dettmer; Roch-Philippe Charles
Journal:  Oncotarget       Date:  2017-04-11

10.  Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.

Authors:  Vicki E Smith; Christopher J McCabe; Alice Fletcher; Martin L Read; Caitlin E M Thornton; Dean P Larner; Vikki L Poole; Katie Brookes; Hannah R Nieto; Mohammed Alshahrani; Rebecca J Thompson; Gareth G Lavery; Iñigo Landa; James A Fagin; Moray J Campbell; Kristien Boelaert; Andrew S Turnell
Journal:  Cancer Res       Date:  2019-10-31       Impact factor: 12.701
  10 in total
  2 in total

Review 1.  Personalized radioiodine therapy for thyroid cancer patients with known disease.

Authors:  Sissy M Jhiang; Peng Cheng; Fadi A Nabhan; Jennifer A Sipos; Chia-Hsiang Menq
Journal:  Fac Rev       Date:  2021-04-07

Review 2.  Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update.

Authors:  Maciej Ratajczak; Damian Gaweł; Marlena Godlewska
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.